Accuray Incorporated (ARAY)
NASDAQ: ARAY · Real-Time Price · USD
1.830
-0.010 (-0.54%)
At close: Nov 20, 2024, 4:00 PM
1.810
-0.020 (-1.09%)
After-hours: Nov 20, 2024, 6:36 PM EST
Accuray Revenue
Accuray had revenue of $101.55M in the quarter ending September 30, 2024, a decrease of -2.26%. This brings the company's revenue in the last twelve months to $444.20M, down -2.37% year-over-year. In the fiscal year ending June 30, 2024, Accuray had annual revenue of $446.55M, down -0.24%.
Revenue (ttm)
$444.20M
Revenue Growth
-2.37%
P/S Ratio
0.41
Revenue / Employee
$450,055
Employees
987
Market Cap
184.03M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 446.55M | -1.05M | -0.24% |
Jun 30, 2023 | 447.61M | 17.70M | 4.12% |
Jun 30, 2022 | 429.91M | 33.62M | 8.48% |
Jun 30, 2021 | 396.29M | 13.36M | 3.49% |
Jun 30, 2020 | 382.93M | -35.86M | -8.56% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Nektar Therapeutics | 93.14M |
Nanobiotix | 45.22M |
BrainsWay | 38.63M |
Cellectis | 36.04M |
Senseonics Holdings | 22.21M |
MediWound | 20.14M |
Profound Medical | 8.98M |
ARAY News
- 14 days ago - Accuray Incorporated (ARAY) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Accuray Reports Fiscal 2025 First Quarter Financial Results - PRNewsWire
- 4 weeks ago - Accuray to Report First Quarter Fiscal 2025 Financial Results on November 6, 2024 - PRNewsWire
- 4 weeks ago - Accuray Appoints Michael Murphy as VP, Corporate Controller - PRNewsWire
- 5 weeks ago - Accuray President and Chief Executive Officer Suzanne Winter Returns from Medical Leave of Absence - PRNewsWire
- 7 weeks ago - Accuray Celebrates Opening of Genolier Innovation Hub in Switzerland, Initiation of CyberKnife® S7™ System Medical Professional Training - PRNewsWire
- 2 months ago - Gifu Prefectural General Medical Center Achieves Milestone with Treatment of the First Cancer Patients in Japan Using the Accuray Radixact® System and VitalHold™ Solution - PRNewsWire
- 2 months ago - Accuray President and Chief Executive Officer Suzanne Winter to Take Temporary Medical Leave of Absence - PRNewsWire